$EXPI
eXp World Holdings Inc

2023 Q2 Form 10-Q Financial Statement

#000155837023013172 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $1.233B $1.415B
YoY Change -12.87% 41.52%
Cost Of Revenue $1.136B $1.308B
YoY Change -13.11% 42.16%
Gross Profit $96.52M $107.3M
YoY Change -10.01% 34.2%
Gross Profit Margin 7.83% 7.58%
Selling, General & Admin $85.42M $95.60M
YoY Change -10.65% 50.78%
% of Gross Profit 88.5% 89.14%
Research & Development $14.89M
YoY Change
% of Gross Profit 15.43%
Depreciation & Amortization $2.779M $2.429M
YoY Change 14.41% 60.12%
% of Gross Profit 2.88% 2.26%
Operating Expenses $85.42M $1.403B
YoY Change -93.91% 42.71%
Operating Profit $11.10M $11.65M
YoY Change -4.74% -29.46%
Interest Expense -$143.0K -$567.0K
YoY Change -74.78% 56600.0%
% of Operating Profit -1.29% -4.87%
Other Income/Expense, Net $1.299M -$629.0K
YoY Change -306.52% 1043.64%
Pretax Income $12.25M $11.02M
YoY Change 11.19% -33.04%
Income Tax $2.831M $1.661M
% Of Pretax Income 23.1% 15.07%
Net Earnings $9.422M $9.359M
YoY Change 0.67% -74.74%
Net Earnings / Revenue 0.76% 0.66%
Basic Earnings Per Share $0.06 $0.06
Diluted Earnings Per Share $0.06 $0.06
COMMON SHARES
Basic Shares Outstanding 153.2M 150.8M
Diluted Shares Outstanding 156.7M 155.8M

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $124.7M $134.9M
YoY Change -7.55% 25.59%
Cash & Equivalents $124.7M $134.9M
Short-Term Investments
Other Short-Term Assets $96.66M $113.7M
YoY Change -14.99% 7.81%
Inventory
Prepaid Expenses
Receivables $135.0M $155.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $356.4M $403.6M
YoY Change -11.7% 16.27%
LONG-TERM ASSETS
Property, Plant & Equipment $15.26M $19.91M
YoY Change -23.36% 78.29%
Goodwill $27.55M $12.95M
YoY Change 112.84% 0.0%
Intangibles $11.73M $7.071M
YoY Change 65.86% -10.88%
Long-Term Investments
YoY Change
Other Assets $71.87M $61.66M
YoY Change 16.56% 302.07%
Total Long-Term Assets $126.4M $103.8M
YoY Change 21.72% 116.34%
TOTAL ASSETS
Total Short-Term Assets $356.4M $403.6M
Total Long-Term Assets $126.4M $103.8M
Total Assets $482.8M $507.4M
YoY Change -4.86% 28.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.321M $5.971M
YoY Change 22.61% -5.49%
Accrued Expenses $128.5M $147.4M
YoY Change -12.82% 23.23%
Deferred Revenue $88.64M $93.57M
YoY Change -5.26% -0.21%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $224.5M $247.1M
YoY Change -9.18% 11.89%
LONG-TERM LIABILITIES
Long-Term Debt $5.000K $2.714M
YoY Change -99.82% 58.16%
Other Long-Term Liabilities $3.000K $720.0K
YoY Change -99.58% 115.57%
Total Long-Term Liabilities $8.000K $2.714M
YoY Change -99.71% 58.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $224.5M $247.1M
Total Long-Term Liabilities $8.000K $2.714M
Total Liabilities $225.6M $250.6M
YoY Change -9.96% 12.4%
SHAREHOLDERS EQUITY
Retained Earnings $18.14M $37.01M
YoY Change -50.99% 1253.58%
Common Stock $701.8M $509.5M
YoY Change 37.75% 50947700.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $257.2M $255.7M
YoY Change
Total Liabilities & Shareholders Equity $482.8M $507.4M
YoY Change -4.86% 28.42%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $9.422M $9.359M
YoY Change 0.67% -74.74%
Depreciation, Depletion And Amortization $2.779M $2.429M
YoY Change 14.41% 60.12%
Cash From Operating Activities $98.02M $53.79M
YoY Change 82.23% -39.24%
INVESTING ACTIVITIES
Capital Expenditures $3.180M -$3.393M
YoY Change -193.72% 2.54%
Acquisitions
YoY Change
Other Investing Activities -$5.000M $0.00
YoY Change
Cash From Investing Activities -$8.180M -$3.393M
YoY Change 141.08% 2.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$47.87M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -54.73M -55.47M
YoY Change -1.33% 1.71%
NET CHANGE
Cash From Operating Activities 98.02M 53.79M
Cash From Investing Activities -8.180M -3.393M
Cash From Financing Activities -54.73M -55.47M
Net Change In Cash 35.11M -5.068M
YoY Change -792.86% -116.52%
FREE CASH FLOW
Cash From Operating Activities $98.02M $53.79M
Capital Expenditures $3.180M -$3.393M
Free Cash Flow $94.84M $57.18M
YoY Change 65.86% -37.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001495932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38493
dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
dei City Area Code
CityAreaCode
360
dei Local Phone Number
LocalPhoneNumber
685-4206
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value per share
dei Trading Symbol
TradingSymbol
EXPI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
153588186
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124714000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121594000
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
88560000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
37789000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1544000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4014000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
134998000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
87262000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8101000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8468000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18138000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20723000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
943000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
236000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
257151000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
247823000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
356373000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
255113000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15224000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18151000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2127000
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
6567000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1703000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11728000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8700000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
65306000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
68676000
CY2023Q2 us-gaap Goodwill
Goodwill
27552000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023Q2 us-gaap Assets
Assets
482782000
CY2022Q4 us-gaap Assets
Assets
381682000
CY2023Q2 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
7321000
CY2022Q4 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
10391000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
88643000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
37789000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
128461000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78944000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
224454000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
127299000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4697000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
694000
CY2023Q2 us-gaap Liabilities
Liabilities
224462000
CY2022Q4 us-gaap Liabilities
Liabilities
132690000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177900083
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153588186
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152839239
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
701806000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
611872000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24311897
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
463738000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
385010000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
1169000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1169000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
9359000
us-gaap Profit Loss
ProfitLoss
10875000
us-gaap Profit Loss
ProfitLoss
18223000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
9422000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
9359000
us-gaap Net Income Loss
NetIncomeLoss
10875000
us-gaap Net Income Loss
NetIncomeLoss
18241000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
258320000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248992000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
482782000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381682000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1232927000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1415060000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2083543000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2425791000
CY2023Q2 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1136411000
CY2022Q2 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1307810000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1913970000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
2235077000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82541000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
91391000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154308000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
166713000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2878000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4210000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5841000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7910000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1221830000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1403411000
us-gaap Operating Expenses
OperatingExpenses
2074119000
us-gaap Operating Expenses
OperatingExpenses
2409700000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11097000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11649000
us-gaap Operating Income Loss
OperatingIncomeLoss
9424000
us-gaap Operating Income Loss
OperatingIncomeLoss
16091000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1299000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2179000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-472000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-143000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-567000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-485000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-884000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1156000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-629000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1694000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1356000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12253000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11020000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11118000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14735000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2831000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1661000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
243000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3488000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
9422000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153249120
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150783418
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152899883
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150049170
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156693959
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155816038
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156119627
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156579590
CY2023Q2 us-gaap Profit Loss
ProfitLoss
9422000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
9359000
us-gaap Profit Loss
ProfitLoss
10875000
us-gaap Profit Loss
ProfitLoss
18223000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
9422000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
9359000
us-gaap Net Income Loss
NetIncomeLoss
10875000
us-gaap Net Income Loss
NetIncomeLoss
18241000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
64000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1182000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
707000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1141000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9486000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8177000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11582000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17100000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
258320000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256872000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
258320000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256872000
us-gaap Profit Loss
ProfitLoss
10875000
us-gaap Profit Loss
ProfitLoss
18223000
us-gaap Depreciation
Depreciation
4163000
us-gaap Depreciation
Depreciation
3570000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1195000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817000
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
361000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-2470000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
608000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-485000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-884000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
18148000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
17028000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5126000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7121000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
65652000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
86835000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
3370000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
-6892000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45266000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22269000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-367000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2236000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-50854000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-25893000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3069000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1152000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
49273000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
31961000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4692000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
157000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
74000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
154168000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
165298000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3433000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8077000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5350000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1179000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9962000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8077000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
78728000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
79820000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1253000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
780000
expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
425000
us-gaap Payments Of Dividends
PaymentsOfDividends
13460000
us-gaap Payments Of Dividends
PaymentsOfDividends
11744000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-90935000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-91209000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
620000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1141000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53891000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64871000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213274000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240781000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1833000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2444000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
837000
expi Property Plant And Equipment Increase Due To Transfer Of Lease Asset
PropertyPlantAndEquipmentIncreaseDueToTransferOfLeaseAsset
1100000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
246000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Roboto';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Roboto';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No reclassifications occurred during the current period.</p>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
67673000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134898000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
105883000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240781000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121594000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
37789000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124714000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
88560000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213274000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38720000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34226000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23552000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19282000
CY2023Q2 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
15168000
CY2022Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
14944000
CY2023Q2 expi Assets Under Development
AssetsUnderDevelopment
56000
CY2022Q4 expi Assets Under Development
AssetsUnderDevelopment
3207000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15224000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18151000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2096000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1954000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4163000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3570000
CY2023Q2 us-gaap Goodwill
Goodwill
27552000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
17070000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5342000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11728000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12856000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4156000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8700000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
683000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
475000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1195000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817000
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174532043
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158300605
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
79599
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
639861
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
192807
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1363055
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177900083
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163286570
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177900083
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163286570
CY2022Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
3885000
expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1338000
expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
1094000
CY2023Q2 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
4129000
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2022Q1 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2022Q1 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2022Q2 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
20000000.0
CY2022Q2 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
20000000.0
CY2022Q3 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
13300000
CY2022Q3 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
13300000
CY2022Q4 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
21089622
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7883740
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6751692
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3222275
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3603951
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5495106
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4735999
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24311897
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11487691
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24311897
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11487691
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
9422000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
9359000
us-gaap Net Income Loss
NetIncomeLoss
10875000
us-gaap Net Income Loss
NetIncomeLoss
18241000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153249120
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150783418
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152899883
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150049170
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3444839
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5032620
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3219744
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6530420
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156693959
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155816038
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156119627
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156579590
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
656776
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1485139
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
588940
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
692237
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
240000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3490000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0220
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.2381
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1232927000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1415060000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2083543000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2425791000
CY2023Q2 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
24729000
CY2022Q2 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
26914000
expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
38056000
expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
44627000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2779000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2429000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5358000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4387000
CY2023Q2 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
8488000
CY2022Q2 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
9230000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
18148000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
17028000
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2365000
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3606000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5126000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7121000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11097000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11649000
us-gaap Operating Income Loss
OperatingIncomeLoss
9424000
us-gaap Operating Income Loss
OperatingIncomeLoss
16091000
CY2023Q2 us-gaap Goodwill
Goodwill
27552000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000

Files In Submission

Name View Source Status
0001558370-23-013172-index-headers.html Edgar Link pending
0001558370-23-013172-index.html Edgar Link pending
0001558370-23-013172.txt Edgar Link pending
0001558370-23-013172-xbrl.zip Edgar Link pending
expi-20230630.xsd Edgar Link pending
expi-20230630x10q.htm Edgar Link pending
expi-20230630x10q001.jpg Edgar Link pending
expi-20230630xex31d1.htm Edgar Link pending
expi-20230630xex31d2.htm Edgar Link pending
expi-20230630xex32d1.htm Edgar Link pending
expi-20230630xex32d2.htm Edgar Link pending
expi-20230630xex3d1.htm Edgar Link pending
expi-20230630xex3d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
expi-20230630_lab.xml Edgar Link unprocessable
expi-20230630_pre.xml Edgar Link unprocessable
expi-20230630x10q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
expi-20230630_def.xml Edgar Link unprocessable
expi-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable